A detailed history of Verition Fund Management LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 193,509 shares of KMPH stock, worth $955,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
193,509
Holding current value
$955,934
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
N/A
193,509 New
193,509 $955,000
Q1 2025

May 15, 2025

BUY
N/A
22,520 New
22,520 $111,000
Q4 2022

Feb 14, 2023

BUY
$4.12 - $5.62 $41,612 - $56,762
10,100 New
10,100 $46,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.